Postinjection Endophthalmitis in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

POOLED ESTIMATES OF INCIDENCE OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS WITH AND WITHOUT TOPICAL ANTIBIOTIC PROPHYLAXIS

Reibaldi, M
Pulvirenti, A
Avitabile, T
Bonfiglio, V
Russo, A
Mariotti, C
Bucolo, C
Mastropasqua, R
Parisi, G
Longo, A

January 2018

Purpose: To assess the effect of topical antibiotic prophylaxis on postoperative endophthalmitis aft...

JAMA Ophthalmol

BAUDIN, F.
BENZENINE, E.
MARIET, A. S.
BRON, A. M.
DAIEN, V.
KOROBELNIK, Jean-Francois
QUANTIN, C.
CREUZOT-GARCHER, C.

December 2018

Importance: The number of patients affected by retinal diseases treated with intravitreal injections...

Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom : incidence, features, risk factors, and outcomes

Lyall, D.A.
Tey, A.
Foot, B.
Roxburgh, S.T.
Virdi, M.
Robertson, Chris
MacEwen, C.J.

December 2012

To describe the incidence, features, management, and risk factors of post-intravitreal anti-VEGF end...

Postinjection Endophthalmitis in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Meredith, Travis A.
McCannel, Colin A.
Barr, Charles
Doft, Bernard H.
Peskin, Ellen
Maguire, Maureen G.
Martin, Daniel F.
Prenner, Jonathan L.

January 2015

To describe the incidence and outcomes of endophthalmitis after intravitreal injections of anti-VEGF...

Postinjection Endophthalmitis in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Meredith, Travis A
McCannel, Colin A
Barr, Charles
Doft, Bernard H
Peskin, Ellen
Maguire, Maureen G
Martin, Daniel F
Prenner, Jonathan L
Group, Comparison of Age-Related Macular Degeneration Treatments Trials Research

April 2015

ObjectiveTo describe the incidence and outcomes of endophthalmitis after intravitreal injections of ...

Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration

Daien, V
Nguyen, Vuong
Essex, Rohan
Morlet, Nigel
Barthelmes, Daniel
Gillies, Mark C

November 2020

Purpose: To assess the incidence, cumulative rate, and long-term outcomes of infectious and noninfec...

Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration

Daien, Vincent
Nguyen, Vuong,
Essex, Rohan
Morlet, Nigel
Barthelmes, Daniel
Gillies, Mark
Banerjee, Gayatri
Study Group, Fight Retinal Blindness!

January 2018

International audiencePURPOSE:To assess the incidence, cumulative rate, and long-term outcomes of in...

The role of preventive topical antibiotic treatment prior to intravitreal injection

Elena Vladimirovna Ageeva
Anna Evgen'yevna Grodnenskaya
Kseniya Aleksandrovna Popova

June 2015

Treatment of wet age-related macular degeneration (AMD) requires frequent intravitreal injections of...

Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.

Shah, Chirag P
Garg, Sunir J
Vander, James F
Brown, Gary C
Kaiser, Richard S
Haller, Julia A
The Post-Injection Endophthalmitis (PIE) Study Team,

October 2011

OBJECTIVE: To describe outcomes of and risk factors for endophthalmitis after intravitreal anti-vasc...

Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.

Shah, Chirag P
Garg, Sunir J
Vander, James F
Brown, Gary C
Kaiser, Richard S
Haller, Julia A
The Post-Injection Endophthalmitis (PIE) Study Team,

October 2011

OBJECTIVE: To describe outcomes of and risk factors for endophthalmitis after intravitreal anti-vasc...

Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: a USA claims analysis

Kiss S
Dugel PU
Khanani AM
Broder MS
Chang E
Sun GH
Turpcu A

August 2018

Szilárd Kiss,1 Pravin U Dugel,2,3 Arshad M Khanani,4 Michael S Broder,5 Eunice Chang,5 Gordon...

Pooled estimates of incidence of endophthalmitis after intravitreal injection of anti–vascular endothelial growth factor agents with and without topical antibiotic prophylaxis

Reibaldi M
Pulvirenti A
Avitabile T
Bonfiglio V
Russo A
Mariotti C
Bucolo C
Mastropasqua R
Parisi G
Longo A.

January 2018

Purpose: To assess the effect of topical antibiotic prophylaxis on postoperative endophthalmitis aft...

Pooled estimates of incidence of endophthalmitis after intravitreal injection of anti–vascular endothelial growth factor agents with and without topical antibiotic prophylaxis

Reibaldi M
Pulvirenti A
Avitabile T
Bonfiglio V
Russo A
Mariotti C
Bucolo C
Mastropasqua R
Parisi G
Longo A.

January 2018

Purpose: To assess the effect of topical antibiotic prophylaxis on postoperative endophthalmitis aft...

POOLED ESTIMATES OF INCIDENCE OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS WITH AND WITHOUT TOPICAL ANTIBIOTIC PROPHYLAXIS

Reibaldi, M
Pulvirenti, A
Avitabile, T
Bonfiglio, V
Russo, A
Mariotti, C
Bucolo, C
Mastropasqua, R
Parisi, G
Longo, A

January 2018

Purpose: To assess the effect of topical antibiotic prophylaxis on postoperative endophthalmitis aft...

Pooled estimates of incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents with and without topical antibiotic prophylaxis

Reibaldi, Michele
Pulvirenti, Alfredo
Avitabile, Teresio
Bonfiglio, Vincenza
Russo, Andrea
Mariotti, Cesare
Bucolo, Claudio
Mastropasqua, Rodolfo
Parisi, Guglielmo
Longo, Antonio

January 2018

PURPOSE: To assess the effect of topical antibiotic prophylaxis on postoperative endophthalmitis af...

POOLED ESTIMATES OF INCIDENCE OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS WITH AND WITHOUT TOPICAL ANTIBIOTIC PROPHYLAXIS

Reibaldi, M
Pulvirenti, A
Avitabile, T
Bonfiglio, V
Russo, A
Mariotti, C
Bucolo, C
Mastropasqua, R
Parisi, G
Longo, A

January 2018

Purpose: To assess the effect of topical antibiotic prophylaxis on postoperative endophthalmitis aft...

JAMA Ophthalmol

BAUDIN, F.
BENZENINE, E.
MARIET, A. S.
BRON, A. M.
DAIEN, V.
KOROBELNIK, Jean-Francois
QUANTIN, C.
CREUZOT-GARCHER, C.

December 2018

Importance: The number of patients affected by retinal diseases treated with intravitreal injections...

Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom : incidence, features, risk factors, and outcomes

Lyall, D.A.
Tey, A.
Foot, B.
Roxburgh, S.T.
Virdi, M.
Robertson, Chris
MacEwen, C.J.

December 2012

To describe the incidence, features, management, and risk factors of post-intravitreal anti-VEGF end...

Postinjection Endophthalmitis in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Meredith, Travis A.
McCannel, Colin A.
Barr, Charles
Doft, Bernard H.
Peskin, Ellen
Maguire, Maureen G.
Martin, Daniel F.
Prenner, Jonathan L.

January 2015

To describe the incidence and outcomes of endophthalmitis after intravitreal injections of anti-VEGF...

Postinjection Endophthalmitis in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Meredith, Travis A
McCannel, Colin A
Barr, Charles
Doft, Bernard H
Peskin, Ellen
Maguire, Maureen G
Martin, Daniel F
Prenner, Jonathan L
Group, Comparison of Age-Related Macular Degeneration Treatments Trials Research

April 2015

ObjectiveTo describe the incidence and outcomes of endophthalmitis after intravitreal injections of ...

Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration

Daien, V
Nguyen, Vuong
Essex, Rohan
Morlet, Nigel
Barthelmes, Daniel
Gillies, Mark C

November 2020

Purpose: To assess the incidence, cumulative rate, and long-term outcomes of infectious and noninfec...

Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration

Daien, Vincent
Nguyen, Vuong,
Essex, Rohan
Morlet, Nigel
Barthelmes, Daniel
Gillies, Mark
Banerjee, Gayatri
Study Group, Fight Retinal Blindness!

January 2018

International audiencePURPOSE:To assess the incidence, cumulative rate, and long-term outcomes of in...

The role of preventive topical antibiotic treatment prior to intravitreal injection

Elena Vladimirovna Ageeva
Anna Evgen'yevna Grodnenskaya
Kseniya Aleksandrovna Popova

June 2015

Treatment of wet age-related macular degeneration (AMD) requires frequent intravitreal injections of...

Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.

Shah, Chirag P
Garg, Sunir J
Vander, James F
Brown, Gary C
Kaiser, Richard S
Haller, Julia A
The Post-Injection Endophthalmitis (PIE) Study Team,

October 2011

OBJECTIVE: To describe outcomes of and risk factors for endophthalmitis after intravitreal anti-vasc...

Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.

Shah, Chirag P
Garg, Sunir J
Vander, James F
Brown, Gary C
Kaiser, Richard S
Haller, Julia A
The Post-Injection Endophthalmitis (PIE) Study Team,

October 2011

OBJECTIVE: To describe outcomes of and risk factors for endophthalmitis after intravitreal anti-vasc...

Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: a USA claims analysis

Kiss S
Dugel PU
Khanani AM
Broder MS
Chang E
Sun GH
Turpcu A

August 2018

Szilárd Kiss,1 Pravin U Dugel,2,3 Arshad M Khanani,4 Michael S Broder,5 Eunice Chang,5 Gordon...

Pooled estimates of incidence of endophthalmitis after intravitreal injection of anti–vascular endothelial growth factor agents with and without topical antibiotic prophylaxis

Reibaldi M
Pulvirenti A
Avitabile T
Bonfiglio V
Russo A
Mariotti C
Bucolo C
Mastropasqua R
Parisi G
Longo A.

January 2018

Purpose: To assess the effect of topical antibiotic prophylaxis on postoperative endophthalmitis aft...

Pooled estimates of incidence of endophthalmitis after intravitreal injection of anti–vascular endothelial growth factor agents with and without topical antibiotic prophylaxis

Reibaldi M
Pulvirenti A
Avitabile T
Bonfiglio V
Russo A
Mariotti C
Bucolo C
Mastropasqua R
Parisi G
Longo A.

January 2018

Purpose: To assess the effect of topical antibiotic prophylaxis on postoperative endophthalmitis aft...

POOLED ESTIMATES OF INCIDENCE OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS WITH AND WITHOUT TOPICAL ANTIBIOTIC PROPHYLAXIS

Reibaldi, M
Pulvirenti, A
Avitabile, T
Bonfiglio, V
Russo, A
Mariotti, C
Bucolo, C
Mastropasqua, R
Parisi, G
Longo, A

January 2018

Purpose: To assess the effect of topical antibiotic prophylaxis on postoperative endophthalmitis aft...

Pooled estimates of incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents with and without topical antibiotic prophylaxis

Reibaldi, Michele
Pulvirenti, Alfredo
Avitabile, Teresio
Bonfiglio, Vincenza
Russo, Andrea
Mariotti, Cesare
Bucolo, Claudio
Mastropasqua, Rodolfo
Parisi, Guglielmo
Longo, Antonio

January 2018

PURPOSE: To assess the effect of topical antibiotic prophylaxis on postoperative endophthalmitis af...

POOLED ESTIMATES OF INCIDENCE OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS WITH AND WITHOUT TOPICAL ANTIBIOTIC PROPHYLAXIS

Reibaldi, M
Pulvirenti, A
Avitabile, T
Bonfiglio, V
Russo, A
Mariotti, C
Bucolo, C
Mastropasqua, R
Parisi, G
Longo, A

January 2018

Purpose: To assess the effect of topical antibiotic prophylaxis on postoperative endophthalmitis aft...

JAMA Ophthalmol

BAUDIN, F.
BENZENINE, E.
MARIET, A. S.
BRON, A. M.
DAIEN, V.
KOROBELNIK, Jean-Francois
QUANTIN, C.
CREUZOT-GARCHER, C.

December 2018

Importance: The number of patients affected by retinal diseases treated with intravitreal injections...

Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom : incidence, features, risk factors, and outcomes

Lyall, D.A.
Tey, A.
Foot, B.
Roxburgh, S.T.
Virdi, M.
Robertson, Chris
MacEwen, C.J.

December 2012

To describe the incidence, features, management, and risk factors of post-intravitreal anti-VEGF end...

Postinjection Endophthalmitis in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Abstract

Extracted data

Postinjection Endophthalmitis in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Abstract

Extracted data

Related items

Related items